OTC and dietary products are the most common cause of drug-induced liver injury Drug-induced acute liver failure is uncommon, but over-the-counter products and dietary/herbal supplements are its most common causes, find researchers.…
EMA recommends treatment for rare kidney condition The European Medicines Agency has recommended the approval of tolvaptan for the treatment of a rare inherited disease, autosomal dominant polycystic kidney disease.…
How pharmacists can start a career in the pharmaceutical industry Have you ever thought about going into the pharmaceutical industry but don’t know where to start? Emma Page finds out what you need to know.…
AstraZeneca spins out early-stage R&D for antibiotic compoundsAstraZeneca is creating a standalone subsidiary to work exclusively on early-stage antibiotics research and development, the company has announced.…
Drug shortage problem needs to be tackled internationallyI wish to comment on Ingrid Torjesen’s interesting news story on tackling ongoing drug shortages ( The Pharmaceutical Journal 2015;294:234). Manufacturers and providers of medicines work in a global marketplace, where decisions affecting supply and price of medi…
EMA recommends approval for advanced lung cancer agent ceritinibThe European Medicines Agency has recommended granting a conditional marketing authorisation for ceritinib (Zykadia) for ALK-positive non-small cell lung cancer in adults with advanced disease.…
Healthcare professionals urged to share information about patients’ medicines Information about a patient’s medicines should be shared by health and social care staff when that person moves from one care setting to another, urges new guidance.…
US FDA launches app that alerts public about drug shortagesA mobile app that allows users to track drug shortages in the United States has been launched by the US Food and Drug Administration.…
US FDA approves antibiotic combination with new beta-lactamase inhibitor The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
Proposals to ‘decriminalise’ dispensing errors may not prevent prosecution for inadvertent mistakes New proposals seek to end the threat of prosecution for inadvertent dispensing errors but there are concerns that pharmacists will not be fully protected when they make an honest mistake.…